Ra Pharmaceuticals to Present at the Cowen and Company 37th Annual Health Care Conference

CAMBRIDGE, Mass.--()--Ra Pharmaceuticals, Inc., (NASDAQ:RARX), a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for the treatment of complement-mediated diseases, today announced that Doug Treco, PhD, President and Chief Executive Officer, will present at the Cowen and Company 37th Annual Health Care Conference on Tuesday, March 7, 2017 at 11:20 a.m. E.T. The conference is being held at the Boston Marriott Copley Place.

The presentation will be webcast live and can be accessed by visiting the investor relations section of the Company’s website, www.rapharma.com. A replay of the presentation will also be available and archived on the site for three weeks.

About Ra Pharmaceuticals

Ra Pharmaceuticals is a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for complement-mediated diseases. The Company discovers and develops peptides and small molecules to target key components of the complement cascade. For more information, please visit: www.rapharma.com.

Contacts

Ra Pharmaceuticals, Inc.
Investors:
Jennifer Robinson, 617.674.9873
jrobinson@rapharma.com
or
Media:
Argot Partners
Eliza Schleifstein, 917.763.8106
eliza@argotpartners.com

Recent Stories

RSS feed for Ra Pharmaceuticals, Inc.

Ra Pharmaceuticals, Inc.